KISIRETIC

This brand name is authorized in Nigeria.

Active ingredients

The drug KISIRETIC contains a combination of these active pharmaceutical ingredients (APIs):

1
UNII FZJ37245UC - AMILORIDE HYDROCHLORIDE
 

Amiloride has mild diuretic and anti-hypertensive activity. It acts primarily in the distal tubule and does not require aldosterone for its action. Amiloride is a mild natriuretic which does not initiate a concomitant decrease in potassium levels.
 
Read more about Amiloride
2
UNII 0J48LPH2TH - HYDROCHLOROTHIAZIDE
 

Hydrochlorothiazide is a diuretic with antihypertensive properties. It acts by inhibiting the renal tubular re-absorption of sodium and chloride ions, which are excreted with an accompanying volume of water. Potassium excretion is also promoted.
 
Read more about Hydrochlorothiazide

Packages

This drug has been approved in Nigeria as follows:

Identifier Form Presentation Description Approval
A11-0347 Tablet KISIRETIC TABLET TAB 75 IU 10 X 10 19 RNW-PP-208263 KISIRETIC TABLET AMILORIDE HYDROCHLORIDE & HYDROCHLOROTHIAZIDE Amiloride hydrochloride powder 750 grams Hydrochlorothiazide powder 7.5kg Corn starch for bulk 15kg Lactose powder 7.5kg Corn starch for paste 2.4kg Methyl paraben 67.5 grams Propyl paraben 13.5 grams Sunset yellow 17.1 grams Allura red 2.7 grams Magnesium stearate 180 grams Talcum powder 375 grams Corn starch for blend 900 grams A11- 0347 Drugs CARDIOVASCULAR SYSTEM Nigerian Products 1010 POM 1 4/20/2021 BIORAJ PHARMACEUTICALS LIMITED, 405, KAIAMA ROAD, IIORIN KWARA STATE 8038099594 biorajpharmaceuticalltd@gmail.com BIORAJ PHARMACEUTICAL LTD, P. O. Box 791 Ilorin, Kwara State, Nigeria 27/07/2023

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group Classification
C03EA01 Hydrochlorothiazide and potassium-sparing agents C Cardiovascular system → C03 Diuretics → C03E Diuretics and potassium-sparing agents in combination → C03EA Low-ceiling diuretics and potassium-sparing agents
Discover more medicines within C03EA01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
NG Registered Drug Product Database A11-0347

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈